The Khorana score for prediction of venous thromboembolism in cancer patients: an individual patient data meta-analysis.
CONCLUSION: The Khorana score was unable to stratify patients with lung cancer based on their VTE risk. Among those with other cancer types, a high-risk score was associated with a 3-fold increased risk of VTE compared with a low-to-intermediate risk score. Thromboprophylaxis was effective and safe in patients with a high-risk Khorana score.
PMID: 32336010 [PubMed - as supplied by publisher]
Source: Thrombosis and Haemostasis - Category: Hematology Authors: van Es N, Ventresca M, Di Nisio M, Zhou Q, Noble S, Crowther M, Briel M, Garcia D, Lyman GH, Macbeth F, Griffiths G, Iorio A, Lawrence M, Neumann I, Brozek J, Guyatt G, Streiff MB, Baldeh T, Florez ID, Alma OG, Agnelli G, Ageno W, Marcucci M, Bozas G, Zul Tags: J Thromb Haemost Source Type: research
More News: Bladder Cancer | Bleeding | Brain | Brain Cancers | Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Gastric (Stomach) Cancer | Gastroenterology | Hematology | Legislation | Lung Cancer | Neurology | Ovarian Cancer | Ovaries | Pancreas | Pancreatic Cancer | Thrombosis